DE69022251D1 - Niedrigdosiertes Aspirin mit gesteuerter Freigabe. - Google Patents

Niedrigdosiertes Aspirin mit gesteuerter Freigabe.

Info

Publication number: DE69022251D1
Authority: DE; Germany
Prior art keywords: controlled release; low dose; dose aspirin; aspirin; low
Prior art date: 1989-01-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69022251T

Other languages

English (en)

Other versions

DE69022251T2 (de

Inventor

Steven Edgar Frisbee

Garret Adare Fitzgerald

William Neil Charman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

STWB Inc

Original Assignee

Sterling Winthrop Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-03

Filing date

1990-01-02

Publication date

1995-10-19

1989-01-03 Priority claimed from US07/293,832 external-priority patent/US4970081A/en

1990-01-02 Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc

1995-10-19 Application granted granted Critical

1995-10-19 Publication of DE69022251D1 publication Critical patent/DE69022251D1/de

1996-05-02 Publication of DE69022251T2 publication Critical patent/DE69022251T2/de

2010-01-03 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DE69022251T 1989-01-03 1990-01-02 Niedrigdosiertes Aspirin mit gesteuerter Freigabe. Expired - Lifetime DE69022251T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/293,832 US4970081A (en)	1989-01-03	1989-01-03	Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A	1989-10-24	1989-10-24

Publications (2)

Publication Number	Publication Date
DE69022251D1 true DE69022251D1 (de)	1995-10-19
DE69022251T2 DE69022251T2 (de)	1996-05-02

Family

ID=26968181

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69022251T Expired - Lifetime DE69022251T2 (de)	1989-01-03	1990-01-02	Niedrigdosiertes Aspirin mit gesteuerter Freigabe.

Country Status (20)

Country	Link
EP (1)	EP0377439B1 (de)
JP (1)	JP2966871B2 (de)
KR (1)	KR0151590B1 (de)
AR (1)	AR244548A1 (de)
AT (1)	ATE127690T1 (de)
AU (1)	AU622254B2 (de)
CA (1)	CA2006975C (de)
DE (1)	DE69022251T2 (de)
DK (1)	DK0377439T3 (de)
ES (1)	ES2076975T3 (de)
FI (1)	FI95776C (de)
GR (1)	GR3017576T3 (de)
HK (1)	HK35396A (de)
IE (1)	IE69270B1 (de)
IL (1)	IL92854A (de)
MX (1)	MX174376B (de)
MY (1)	MY104871A (de)
NO (1)	NO177127C (de)
NZ (1)	NZ231954A (de)
PT (1)	PT92780B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5851579A (en) *	1996-10-28	1998-12-22	Eastman Chemical Company	Aqueous enteric coating compositions
SK284690B6 (sk) *	1997-06-11	2005-09-08	The Procter And Gamble Company	Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu
AU2006203890A1 (en) *	2005-01-06	2006-07-13	Gilead Sciences, Inc.	Sustained release pharmaceutical formulations comprising ranolazine
WO2008140459A1 (en) *	2007-05-16	2008-11-20	Fmc Corporation	Solid form
KR101109633B1 (ko) *	2007-08-03	2012-01-31	제이더블유중외제약 주식회사	활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
CN110090206A (zh) *	2018-01-30	2019-08-06	日东电工株式会社	经皮吸收型制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE14379T1 (de) *	1981-04-27	1985-08-15	Haessle Ab	Pharmazeutisches praeparat.
GB8519310D0 (en) *	1985-07-31	1985-09-04	Zyma Sa	Granular active substances
GB8521494D0 (en) *	1985-08-29	1985-10-02	Zyma Sa	Controlled release tablet
NZ228557A (en) *	1988-04-05	1990-11-27	Kyowa Hakko Kogyo Kk	Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions
US4866046A (en) *	1988-05-31	1989-09-12	Top Laboratories, Inc.	Low-dosage sublingual aspirin

1989
- 1989-12-20 IE IE412089A patent/IE69270B1/en not_active IP Right Cessation
- 1989-12-20 AU AU47194/89A patent/AU622254B2/en not_active Expired
- 1989-12-21 NZ NZ231954A patent/NZ231954A/en unknown
- 1989-12-22 IL IL9285489A patent/IL92854A/en not_active IP Right Cessation
- 1989-12-22 MX MX1888389A patent/MX174376B/es unknown
1990
- 1990-01-02 DK DK90100032.3T patent/DK0377439T3/da active
- 1990-01-02 AT AT90100032T patent/ATE127690T1/de not_active IP Right Cessation
- 1990-01-02 NO NO900009A patent/NO177127C/no not_active IP Right Cessation
- 1990-01-02 EP EP90100032A patent/EP0377439B1/de not_active Expired - Lifetime
- 1990-01-02 CA CA002006975A patent/CA2006975C/en not_active Expired - Lifetime
- 1990-01-02 ES ES90100032T patent/ES2076975T3/es not_active Expired - Lifetime
- 1990-01-02 DE DE69022251T patent/DE69022251T2/de not_active Expired - Lifetime
- 1990-01-03 AR AR90315876A patent/AR244548A1/es active
- 1990-01-03 PT PT92780A patent/PT92780B/pt not_active IP Right Cessation
- 1990-01-03 FI FI900017A patent/FI95776C/fi active IP Right Grant
- 1990-01-03 MY MYPI90000004A patent/MY104871A/en unknown
- 1990-01-03 KR KR1019900000044A patent/KR0151590B1/ko not_active IP Right Cessation
- 1990-01-04 JP JP2000198A patent/JP2966871B2/ja not_active Expired - Lifetime
1995
- 1995-09-29 GR GR950402381T patent/GR3017576T3/el unknown
1996
- 1996-02-29 HK HK35396A patent/HK35396A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI900017L (fi)	1990-07-04
HK35396A (en)	1996-03-08
PT92780B (pt)	1997-12-31
NO177127B (no)	1995-04-18
JP2966871B2 (ja)	1999-10-25
DK0377439T3 (da)	1995-10-30
CA2006975C (en)	2000-04-04
MX174376B (es)	1994-05-11
DE69022251T2 (de)	1996-05-02
AU622254B2 (en)	1992-04-02
ATE127690T1 (de)	1995-09-15
JPH02262520A (ja)	1990-10-25
NO900009L (no)	1990-07-04
IE69270B1 (en)	1996-08-21
NO900009D0 (no)	1990-01-02
IL92854A0 (en)	1990-09-17
IL92854A (en)	1994-11-28
FI95776B (fi)	1995-12-15
AR244548A1 (es)	1993-11-30
CA2006975A1 (en)	1990-07-03
IE894120L (en)	1990-07-03
ES2076975T3 (es)	1995-11-16
EP0377439B1 (de)	1995-09-13
AU4719489A (en)	1990-07-12
NO177127C (no)	1995-07-26
KR900011453A (ko)	1990-08-01
EP0377439A3 (de)	1991-02-06
MY104871A (en)	1994-06-30
FI900017A0 (fi)	1990-01-03
EP0377439A2 (de)	1990-07-11
GR3017576T3 (en)	1995-12-31
FI95776C (fi)	1996-03-25
MX18883A (es)	1993-09-01
NZ231954A (en)	1991-12-23
PT92780A (pt)	1990-07-31
KR0151590B1 (ko)	1998-10-15

Publication	Publication Date	Title
NO905125L (no)	1991-05-29	Administrerings-innretning.
DE58902185D1 (de)	1992-10-08	Ampulle.
DE68912814D1 (de)	1994-03-17	Spritzen.
FI902502A0 (fi)	1990-05-21	Ampull.
DE58900730D1 (de)	1992-02-27	Spritzentablett.
DE3778106D1 (de)	1992-05-14	Dosierungsform mit verzoegernder freisetzung.
FI906367A0 (fi)	1990-12-21	Terapeutiska nukleosider.
IT1226464B (it)	1991-01-16	Formulazione a rilascio controllato.
FI913899A0 (fi)	1991-08-19	Terapeutiska aerosolblandningar.
DE69007094D1 (de)	1994-04-07	Blockierspritze.
FI891327A0 (fi)	1989-03-21	Roerformig protes.
ATE120194T1 (de)	1995-04-15	Therapeutische nuleoside.
FI905859L (fi)	1991-05-29	Funktionella vaetskor.
DE59004689D1 (de)	1994-03-31	Schichtstoff.
DE3882739D1 (de)	1993-09-16	Matrix-zubereitungen mit verzoegerter freisetzung.
FI890176A0 (fi)	1989-01-13	Preventivmedel:mikrokondom.
DE58908737D1 (de)	1995-01-19	Lithotriptor.
NO891589D0 (no)	1989-04-18	Automatisk sprayboks.
NO882653D0 (no)	1988-06-15	Doseringsform.
AR240257A1 (es)	1990-03-30	Jeringa autodescartable.
DE68907177D1 (de)	1993-07-22	Dosierungsform.
FI893835L (fi)	1990-02-17	Laekemedel.
FI904854A0 (fi)	1990-10-02	Terapeutiska nukleosider.
DE69001002D1 (de)	1993-04-08	Vorratsbehaelter mit verzoegerter freigabe.
FI895677A0 (fi)	1989-11-28	Dispenser.

Legal Events

Date	Code	Title	Description
1996-10-10	8364	No opposition during term of opposition